BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
IGF1
,
Apoptosis
,
Inflammatory disorder
,
Hypothalamus
,
Neocentromeres
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antibody affinity
Summary
General Info
Curated Studies
Most Correlated Studies
B cells activated with anti-IgM and CpG DNA then treated with high affinity HIV gp120 protein R66M
Influence of anti-CD25 mAb on the transcriptome of activated PBMC
B-cell lymphoma SUDHL4 cells stimulated with both megaCD40L and IgM/G
RNA immunoprecipitation (RIP-Chip) analysis for EWS-bound mRNA in HeLa cells
Gene Expression in MYC+ and MYC- mouse germinal center B cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Important parameters for evaluation of antibody avidity by immunosorbent assay.
Waning antibody levels and avidity: implications for MMR vaccine-induced protection.
Clinical applications of antibody avidity and immunoglobulin M testing in acute HCV infection.
Optimisation of antibody affinity by ribosome display using error-prone or site-directed mutagenesis…
Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys With DMD
Monoclonal Antibodies in Clostridium Difficile Infection
PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial
Rituximab to Treat Neuropathy With Anti-MAG Antibodies
Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ